COI Declaration Policy in Medical Journals: From Authors to Editors.
Saved in:
| Title: | COI Declaration Policy in Medical Journals: From Authors to Editors. |
|---|---|
| Authors: | Yang, Lili1 (AUTHOR), Shao, Jufang2 (AUTHOR) nancysjf@163.com |
| Source: | Learned Publishing. Jul2026, Vol. 39 Issue 3, p1-3. 3p. |
| Abstract: | Key Points: Medical journal editors commonly have widespread financial relationships with pharmaceutical or device companies, which may unconsciously influence the whole manuscript processing.The transparency and comprehensiveness of editor's public COI disclosure is far less sufficient.It is important to clearly and comprehensively outline the COI disclosure requirements for editors and the editorial team.It is important for medical journals to establish a mandatory interest disclosure and recusal mechanism for dealing with the situations when the editors act as the coauthors. [ABSTRACT FROM AUTHOR] |
| Copyright of Learned Publishing is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Engineering Source |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
